TF and hepatocellular carcinoma: Similarly to our results, Lian et al. reported a significant correlation between mean TF and tumor burden, and over 36 months, patients with a TF above 10% had poorer survival, especially in stage C HCC, highlighting TF potential as a prognostic marker in advanced HCC [28].